The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Gopalakrishnan, Vancheswaran, Helmink, Beth A., Spencer, Christine N., Reuben, Alexandre, Wargo, Jennifer A.·2018·Cancer Cell

Cited by (1,000)

Items 601–700 of 1,000

  1. Protective effect of the branched short‐chain fatty acid isobutyrate on intestinal damage in weaned piglets through intestinal microbiota remodeling
    Xiuyu Fang, Zhengyi Wang, Qinrui Chen, Yongqing Du, Haowen Sun, Haiyang Liu, Ye Feng, Zhongyu Li, Teng Teng, Baoming Shi · 2024 · Journal of the Science of Food and Agriculture
  2. Breath methane to hydrogen ratio as a surrogate marker of intestinal dysbiosis in head and neck cancer
    Nuwan Dharmawardana, Thomas R. Goddard, Charmaine M. Woods, David Ian Watson, Ross N. Butler, Eng Hooi Ooi, Roger Yazbeck · 2020 · Scientific Reports
  3. Vitamin D: Promises on the Horizon and Challenges Ahead for Fighting Pancreatic Cancer
    D. Wei, Liang Wang, Xiang-Sheng Zuo, R. Bresalier · 2021 · Cancers
  4. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
    Youssef Bouferraa, Andrea Chedid, Ghid Amhaz, Ahmed El Lakkiss, Deborah Mukherji, Sally Naji Temraz, Ali I. Shamseddine · 2021 · International Journal of Molecular Sciences
  5. The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
    Giovanni Brandi, Silvia Turroni, Florencia M. McAllister, Giorgio Frega · 2021 · International Journal of Molecular Sciences
  6. The Molecular Effects of Dietary Acid Load on Metabolic Disease (The Cellular PasaDoble: The Fast-Paced Dance of pH Regulation)
    Morgan Williamson, Naïma Moustaïd‐Moussa, Lauren Gollahon · 2021 · Frontiers in Molecular Medicine
  7. Integrated Metagenomic and Transcriptomic Analyses Reveal the Dietary Dependent Recovery of Host Metabolism From Antibiotic Exposure
    Bingbing Li, Huihui Qiu, Ningning Zheng, Gaosong Wu, Yu Gu, Jing Zhong, Ying Hong, Junli Ma, Wen Zhou, Lili Sheng et al. · 2021 · Frontiers in Cell and Developmental Biology
  8. Intestinal flora characteristics of advanced non‐small cell lung cancer in China and their role in chemotherapy based on metagenomics: A prospective exploratory cohort study
    Min Zhang, Dan Liu, Huan Zhou, Xiangjun Liu, Xiuhua Li, Ye Cheng, Bing Xin Gao, Jun Chen · 2021 · Thoracic Cancer
  9. The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)
    Amr Mohamed, Sylvia L. Asa, Thomas S. McCormick, Hilmi Al-Shakhshir, Arvind N. Dasari, Mauricio Retuerto, Iman Salem, Lee Mayer Ocuin, David Lawrence Bajor, Richard Tsong Lee et al. · 2022 · Current Issues in Molecular Biology
  10. Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis
    Ruiyi Deng, Hua Zhang, Yuan Li, Yanyan Shi · 2022 · Journal of Immunotherapy
  11. Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
    Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, Anna Spreafico · 2023 · International Journal of Molecular Sciences
  12. Changes in the Human Gut Microbiome Caused by the Short-Term Impact of Lactic Acid Bacteria Consumption in Healthy People
    Gryaznova Mariya Vladimirovna, Smirnova Yuliya Dmitrievna, Inna Yu. Burakova, Mikhail Syromyatnikov, Pavel A. Chizhkov, Е. С. Попов, Vasily N. Popov · 2023 · Probiotics and Antimicrobial Proteins
  13. The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588
    Massimiliano Cazzaniga, Marco Cardinali, Francesco Di Pierro, Giordano Bruno Zonzini, Chiara Maria Palazzi, Aurora Gregoretti, Nicola Zerbinati, Luigina Guasti, Maria Rosaria Matera, Ilaria Cavecchia et al. · 2024 · Microorganisms
  14. TRP channels in cancer: Therapeutic opportunities and research strategies
    Jiahui Xu, Ziming Wang, Yuqing Niu, Yuping Tang, Yuwei Wang, Jumin Huang, Elaine Lai‐Han Leung · 2024 · Pharmacological Research
  15. Evaluation of the efficacy of probiotics in the chemoradiotherapy of colorectal cancer: a meta-analysis of Randomized Controlled Trials
    Rong Yang, Wei Yong Liu, Shuiyan Cai, Xiurong Feng, Yongjing Chen, Xiangyu Cheng, Junjie Ma, Wenjing Ma, Zhihui Tian, Wenhui Yang · 2025 · BMC Gastroenterology
  16. Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis
    Yan Peng, Qin Tang, Shiming Wu, Chengzhi Zhao · 2025 · BMC Infectious Diseases
  17. Microbiome as therapeutics in vesicular delivery
    Gautam Singhvi, Vishal Girdhar, Shalini Patil, Gaurav Gupta, Philip M. Hansbro, Kamal Dua · 2018 · Biomedicine & Pharmacotherapy
  18. An assessment of Oxford Nanopore sequencing for human gut metagenome profiling: A pilot study of head and neck cancer patients
    Thidathip Wongsurawat, Mayumi Nakagawa, Omar T. Atiq, Hannah N. Coleman, Piroon Jenjaroenpun, James I. Allred, Angela B Trammel, Pantakan Puengrang, David Wayne Ussery, Intawat Nookaew · 2019 · Journal of Microbiological Methods
  19. Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
    Simone A. Minnie, Geoffrey R. Hill · 2021 · Frontiers in Immunology
  20. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics
    Jie Zhang, Zhujiang Dai, Cheng Yan, Wenjie Zhang, Daorong Wang, Dong Tang · 2021 · Clinical & Translational Oncology
  21. Negative correlations of psychological distress with quality of life and immunotherapy efficacy in patients with advanced NSCLC.
    Ziran Bi, Wen Li, Jie Zhao, Lulian Pang, Yanyan Jing, Xiuqing Zhang, Senbang Yao, Xiangxiang Yin, He Zuo, Huaidong Cheng · 2022 · PubMed Central
  22. Ultra-Processed Diets and Endocrine Disruption, Explanation of Missing Link in Rising Cancer Incidence Among Young Adults
    Almir Fajkić, Orhan Lepara, Rijad Jahić, Almira Hadžović-Džuvo, Andrej Belančić, Alexander L. Chupin, Doris Pavković, Emina Karahmet Sher · 2025 · Cancers
  23. Probiotic Supplement Preparation Relieves Test Anxiety by Regulating Intestinal Microbiota in College Students
    Qin Qi, Hui Liu, Yulu Yang, Yifei Wang, Chaofei Xia, Puyuan Tian, Jing Wei, Shengjie Li, Tingtao Chen · 2021 · Disease Markers · Retracted
  24. Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
    Isabella K. T. M. Takenaka, Thais Fernanda Bartelli, Alexandre Defelicibus, Juan Martín Sendoya, Mariano Golubicki, Juan Robbio, Marianna Sampaio Serpa, Gabriela Pereira Branco, Luana B. C. Santos, Laura Carolina López Claro et al. · 2022 · Frontiers in Oncology
  25. Standards for Collection, Preservation, and Transportation of Fecal Samples in TCM Clinical Trials
    Wenquan Su, Yawei Du, Fengmei Lian, Hui Wu, Xinrong Zhang, Wenli Yang, Yunfeng Duan, Yuanming Pan, Weijng Liu, Aiming Wu et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  26. Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study
    Evan Yi-Wen Yu, Hao Zhang, Yuanqing Fu, Ya‐Ting Chen, Qiu‐Yi Tang, Yuxiang Liu, Yan‐Xi Zhang, Shi-Zhi Wang, Anke Wesselius, Wenchao Li et al. · 2022 · Current Oncology
  27. Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota
    Amog Prakash, Milad Nourianpour, Abiola Catherine Senok, William Atiomo · 2022 · Cells
  28. Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
    Xuenan Peng, Caifeng Gong, Wen Zhang, Aiping Zhou · 2023 · Frontiers in Oncology
  29. Urogenital tract and rectal microbiota composition and its influence on reproductive outcomes in infertile patients
    Yong‐Hong Dong, Zhong Zhi Fu, Ningnan Zhang, Jingyi Shao, Jie Shen, En Yang, Shiyi Sun, Zhimin Zhao, An Xiao, Chen‐Jian Liu et al. · 2023 · Frontiers in Microbiology
  30. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
    Yusuke Inoue, Naoki Inui, Masato Karayama, Kazuhiro Asada, Masato Fujii, Shun Matsuura, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Masaki Ikeda et al. · 2023 · Cancer Immunology Immunotherapy
  31. The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma
    Liqiu Kou, Xiaolu Xie, Xiu Chen, Bo Li, Jun Li, Yaling Li · 2023 · Cancer Immunology Immunotherapy
  32. Depression promotes breast cancer progression by regulating amino acid neurotransmitter metabolism and gut microbial disturbance
    Sisi Lin, Zhe Zhou, Yiming Qi, Jiabing Chen, Guoshu Xu, Yunfu Shi, Zhihong Yu, Mingqian Li, Kequn Chai · 2024 · Clinical & Translational Oncology
  33. Tumor-associated microbiome features of metastatic colorectal cancer and clinical implications
    Ho Jung An, Mira A. Partha, HoJoon Lee, Billy T. Lau, Dmitri S. Pavlichin, Alison Figueroa Almeda, Anna C. Hooker, Gi Won Shin, Hanlee P. Ji · 2024 · Frontiers in Oncology
  34. Artificial Intelligence for Precision Oncology of Triple-Negative Breast Cancer: Learning from Melanoma
    Ornella Garrone, Caterina A. M. La Porta · 2024 · Cancers
  35. Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children
    Linli Han, Xu Liu, Yue Lan, Y. Hua, Zhen-Xin Fan, Yi-Fei Li · 2024 · Frontiers in Immunology
  36. Genetic evidence of bidirectional mendelian randomization study on the causality between gut microbiome and respiratory diseases contributes to gut-lung axis
    Xiaoqing Zhou, Shuyan Shen, Zhen Wang · 2024 · Scientific Reports
  37. Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
    Piyada Sitthideatphaiboon, Nicha Somlaw, Nicha Zungsontiporn, Pongsakorn Ouwongprayoon, Narittee Sukswai, Krittiya Korphaisarn, Naravat Poungvarin, Chatchawit Aporntewan, Nattiya Hirankarn, Chanida Vinayanuwattikun et al. · 2024 · Scientific Reports
  38. Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity
    Zhuangzhuang Shi, Wenxing Jiang, Hongwen Li, Yue Zhang, Weili Xue, Yingjun Wang, Mingzhi Zhang, Zhaoming Li · 2025 · BMC Medicine
  39. Activity‐Based Protein Profiling of Bile Salt Hydrolysis in the Human Gut Microbiome with Beta‐Lactam or Acrylamide‐Based Probes
    Kristoffer R. Brandvold, Carson J. Miller, Regan F. Volk, Bryan Killinger, Christopher Whidbey, Aaron Wright · 2020 · ChemBioChem
  40. Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy
    Hyunmin Koo, Casey D. Morrow · 2021 · BMC Microbiology
  41. Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer
    Xilun Cui, Changfeng Li, Jing Zhong, Yuanda Liu, Pengtuo Xiao, Chang Liu, Mengwei Zhao, Wei Yang · 2025 · Frontiers in Immunology
  42. The current status and prospects of gut microbiota combined with PD-1/PD-L1 inhibitors in the treatment of colorectal cancer: a review
    Min Deng, Xiaoyü Li, Huiming Wu, Dingwen Xue, Yize Wang, Renkai Guo, Yipeng Cui, Chenfei Jin, Fei luo, Huiyu Li · 2025 · BMC Gastroenterology
  43. Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer
    Sonakshi Modeel, Sneha Siwach, Padma Dolkar, Meenu Chaurasia, Pankaj Yadav, Apoorva Atri, Aarzoo Yadav, Tarana Negi, Ram Krishan Negi · 2025 · Cancer Pathogenesis and Therapy
  44. Gut microbiome and gastric cancer: microbial interactions and therapeutic potential
    Maged El-Ghannam, Moataz Hassan Hassanien, Yosry Abdelrahman Ameen, Emad Abdelwahab Turky, Gamal Mohammed ELattar, Ahmed Ali El Ray, Mohammed Darwish Eltalkawy · 2025 · Gut Pathogens
  45. Antibiotic exposure windows and the efficacy of immune checkpoint blockers in patients with cancer: a meta-analysis
    Litang Huang, Xi Chen, Li Qun Zhou, Qiuli Xu, Jingyuan Xie, Ping Zhan, Tangfeng Lv, Yong Song · 2021 · Annals of Palliative Medicine
  46. From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade
    Ali Hussein Abdel Sater, Youssef Bouferraa, Ghid Amhaz, Yolla Haibe, Ahmed El Lakkiss, Ali I. Shamseddine · 2022 · Frontiers in Oncology
  47. Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome
    Huijuan Jiang, Xiaoyu Zhao, Mengtong Zang, Rong Fu, Zonghong Shao, Chunyan Liu · 2022 · Oxidative Medicine and Cellular Longevity
  48. Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
    Michael B. Atkins, Hamzah Abu‐Sbeih, Paolo A. Ascierto, Michael Bishop, Daniel S. Chen, Madhav V. Dhodapkar, Leisha A. Emens, Marc S. Ernstoff, Robert Louis Ferris, Tim F. Greten et al. · 2022 · Journal for ImmunoTherapy of Cancer
  49. In-silico computational approaches to study microbiota impacts on diseases and pharmacotherapy
    Hassan Shokri Garjan, Yadollah Omidi, Mehdi Poursheikhali Asghari, Reza Ferdousi · 2023 · Gut Pathogens
  50. Comprehensive analysis of microbiota signature across 32 cancer types
    Xia Yang, Huimin An, Yongtao He, Guoxiang Fu, Zhinong Jiang · 2023 · Frontiers in Oncology
  51. The animal's microbiome and cancer: A translational perspective
    Catarina Aluai‐Cunha, Catarina Alves Pinto, Alexandra Correia, Cláudia R. Serra, Andreia Alexandra Ferreira Santos · 2023 · Veterinary and Comparative Oncology
  52. The microbiome in the pathogenesis of lung cancer
    Sainan Miao, Huan Qiu · 2023 · Apmis
  53. Promising and Minimally Invasive Biomarkers: Targeting Melanoma
    Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico · 2023 · Cells
  54. Lifestyle Medicine for the Prevention and Treatment of Pancreatitis and Pancreatic Cancer
    Sruthi Kapliyil Subramanian, Bhaumik S. Brahmbhatt, Jennifer M. Bailey, Nirav C Thosani, Pritesh R. Mutha · 2024 · Diagnostics
  55. Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo
    Yingying Yang, Junru Shen, Peiyuan Deng, Ping Chen · 2024 · Cancer Biology & Therapy
  56. Mechanism of probiotics in the intervention of colorectal cancer: a review
    Qin‐Qin Li, Dongmei Liu, Minghua Liang, Yichao Zhu, Muhammad Yousaf, Yaping Wu · 2024 · World Journal of Microbiology and Biotechnology
  57. Gut Microbiota and Exercise: Probiotics to Modify the Composition and Roles of the Gut Microbiota in the Context of 3P Medicine
    Yongfu Liu, Yuting Hu, Baolei Ma, Zijun Wang, Bowen Wei · 2025 · Microbial Ecology
  58. Prognostic Biomarkers for Melanoma Immunotherapy
    Chris Twitty, Laura Ann Huppert, ADIL I. DAUD · 2020 · Current Oncology Reports
  59. Are silver nanoparticles better than triclosan as a daily antimicrobial? Answers from the perspectives of gut microbiome disruption and pathogenicity
    Mingzhu Li, Chengdong Zhang · 2020 · The Science of The Total Environment
  60. Extracellular Vesicles and Their Role in the Spatial and Temporal Expansion of Tumor–Immune Interactions
    Simone Lipinski, Katharina Tiemann · 2021 · International Journal of Molecular Sciences
  61. Modeling the Th17 and Tregs Paradigm: Implications for Cancer Immunotherapy
    Karla Fabiola Corral‐Jara, Gonçalo Rosas da Silva, Nora Alma Fierro, Vassili Soumelis · 2021 · Frontiers in Cell and Developmental Biology
  62. Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-up
    Anne Loes van den Boom, Birgit D. A. Lavrijssen, Jesse Fest, M. Arfan Ikram, Bruno H. Ch. Stricker, Casper H.J. van Eijck, Rikje Ruiter · 2022 · Cancer Epidemiology
  63. The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient Survival
    Xin Li, Xiaoqi Wang, Ruihao Huang, Andres Stucky, Xuelian Chen, Lan Ping Sun, Qin Wen, Yunjing Zeng, Hansel M. Fletcher, Charles Wang et al. · 2022 · Cancers
  64. Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope?
    Erez N. Baruch, Tanmay Gaglani, Jennifer Ann Wargo · 2021 · Therapeutic Advances in Medical Oncology
  65. The multi-kingdom cancer microbiome
    Anders B. Dohlman, Xiangyu Pan, Laurence Zitvogel, Iliyan Dimitrov Iliev · 2025 · Nature Microbiology
  66. Does a link exist between oral microbiota and oral squamous cell carcinoma? A review of current insights
    Luigì Santacroce, Emilio Jirillo, Lucrezia Bottalico, Skënder Topi, Pier Carmine Passarelli, Antonio Mancini, Antonio D’Addona, Franklin Garcı́a-Godoy, Veronica Folliero, Marica Colella · 2025 · Journal of Oral Microbiology
  67. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer
    Travis T. Sims, Lauren Elizabeth Colbert, Ann H. Klopp · 2020 · Journal of Immunotherapy and Precision Oncology
  68. Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review
    Elena Giudice, Vanda Salutari, Caterina Ricci, Camilla Nero, Maria Vittoria Carbone, Viola Ghizzoni, Lucia Musacchio, Chiara Landolfo, Maria Teresa Perri, Floriana Camarda et al. · 2021 · Critical Reviews in Oncology/Hematology
  69. Long-term gut microbiome dynamics inDrosophila melanogasterreveal environment-specific associations between bacterial taxa at the family level
    Rupert Mazzucco, Christian Schlötterer · 2021 · Proceedings of the Royal Society B Biological Sciences
  70. Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy
    Hufei Wang, Kangjia Luo, Zilong Guan, Zhi Li, Jun Yong Xiang, Suwen Ou, Yangbao Tao, Songlin Ran, Jinhua Ye, Tianyi Ma et al. · 2022 · Frontiers in Genetics
  71. The role of the microbiome in pancreatic oncogenesis
    Donnele Daley · 2022 · International Immunology
  72. Characterization of Changes in Penile Microbiome Following Pediatric Circumcision
    Kirtishri Mishra, Ilaha Isali, Mohit Sindhani, Megan C. Prunty, Spencer Bell, Amr Mahran, Giovanni Battista Damiani, Mahmoud Afif Ghannoum, Mauricio Retuerto, Alexander Kutikov et al. · 2022 · European Urology Focus
  73. The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review
    Giuseppe Schirò, Salvatore Iacono, Carmela Rita Balistreri · 2023 · Neurology International
  74. The Role of the Mycobiome in Women’s Health
    Michelle Marie Esposito, Savannah Patsakos, Larisa Borruso · 2023 · Journal of Fungi
  75. Hydrobiome of Thermal Waters: Potential Use in Dermocosmetics
    M. Lourdes Mourelle, Carmen P. Gómez, José Luis Legido · 2023 · Cosmetics
  76. Tumor Microbial Communities and Thyroid Cancer Development—The Protective Role of Antioxidant Nutrients: Application Strategies and Future Directions
    Francesca Gorini, Alessandro Tonacci · 2023 · Antioxidants
  77. Acute copper oxide nanoparticles exposure alters zebrafish larval microbiome
    Satheeswaran Balasubramanian, Mariam Azeezuddin Haneen, Gaurav Sharma, Ekambaram Perumal · 2023 · Life Sciences
  78. Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota
    Wen Xie, Aditi Sharma, Hitesh Kumar Kaushik, Lalit Sharma, Nistha, Md. Khalid Anwer, Monika Sachdeva, Gehan M. Elossaily, Yingbo Zhang, Ramkumar Pillappan et al. · 2024 · Heliyon
  79. Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals
    Matteo Sangermani, I. Desiati, Solveig M. Jørgensen, Jia V. Li, Trygve Andreassen, T. Bathen, G. Giskeødegård · 2024 · Gut microbes
  80. Multi-omics analysis reveals associations between gut microbiota and host transcriptome in colon cancer patients
    Yuling Qin, Qiang Wang, Qiumei Lin, Fengfei Liu, Xiaolan Pan, Caibiao Wei, Junxian Chen, Taijun Huang, Min Fang, Weilong Yang et al. · 2025 · mSystems
  81. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles
    Sirinya Sitthirak, Manida Suksawat, Jutarop Phetcharaburanin, Arporn Wangwiwatsin, Poramate Klanrit, Nisana Namwat, Narong Khuntikeo, Attapol Titapun, Apiwat Jarearnrat, Sakkarn Sangkhamanon et al. · 2022 · PeerJ
  82. 3D Organoids: An Untapped Platform for Studying Host–Microbiome Interactions in Esophageal Cancers
    Samuel P. Flashner, Kelley S. Yan, Hiroshi Nakagawa · 2021 · Microorganisms
  83. Plasmid DNA and mRNA delivery: Approaches and challenges
    Arun Kumar Singh, Karan Goel, Meenakshi Dhanawat · 2025 · Advances in immunology
  84. Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors
    Frank R. Rojas, Edwin Roger Parra, Ignacio Ivan Wistuba, Cara Haymaker, Luisa M. Solis Soto · 2022 · Cancers
  85. Is Fasting Good When One Is at Risk of Liver Cancer?
    Iulia Minciună, Laurens A. van Kleef, Horia Ştefănescu, Bogdan Procopeț · 2022 · Cancers
  86. The Interaction between Gut Microbiota and Host Amino Acids Metabolism in Multiple Myeloma
    Qin Zhao Yang, Yumou Wei, Yinghong Zhu, Jiaojiao Guo, Jingyu Zhang, Yanjuan He, Xin Li, Jing Liu, Wen Zhou · 2023 · Cancers
  87. Antibiotics Significantly Decrease the Survival of Head and Neck Carcinoma Patients with Immunotherapy: A Real-World Analysis of More Than 3000 Cases
    Saskia Preißner, Max Heiland, Robert Preißner, Markus Wirth, Barbara Wollenberg · 2023 · Cancers
  88. Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade
    J. Gorgulho, C. Roderburg, F. Beier, C. Bokemeyer, T. Brümmendorf, T. Luedde, S. Loosen · 2023 · Frontiers in Immunology
  89. Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review
    Angela E. Russo, Areeba Memon, Shahid Sattar Ahmed · 2024 · Clinical Genitourinary Cancer
  90. Immunological Drug–Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor Therapies
    Sophie Grice, Anna Claire Olsson-Brown, Dean John Naisbitt, Sean Hammond · 2024 · Chemical Research in Toxicology
  91. Effects of Lactobacillus plantarum on Broiler Health: Integrated Microbial and Metabolomics Analysis
    Lei Wang, Fazul Nabi, Xiaohu Zhang, Guangyu Zhou, Qurban Ali Shah, Siyuan Li, Yaozhong Lu, Siyang Mu, Xiaohui Zhu, Zhengrong Lin et al. · 2024 · Probiotics and Antimicrobial Proteins
  92. Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review
    Adi David, Shaked Lev Ari · 2024 · Integrative Cancer Therapies
  93. PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis
    Dakota B. Poschel, John David Klement, Alyssa D. Merting, Chunwan Lu, Yang Zhao, Dafeng Yang, Wei Lie Xiao, Huabin Zhu, Ponnala Rajeshwari, Michael L. Toscano et al. · 2024 · Cell Reports
  94. Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach
    Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, C. Schwintner, Joël Doré, Nathalie Corvaia · 2024 · Microorganisms
  95. Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
    Valentina Salvestrini, G. Conti, F. D'Amico, G. Cristiano, Marco Candela, M. Cavo, S. Turroni, A. Curti · 2025 · Cancer Medicine
  96. Evaluating the analytical performance of direct-to-consumer gut microbiome testing services
    Stephanie L. Servetas, Kristine Gierz, Diane Hoffmann, Jacques Ravel, Scott A. Jackson · 2026 · Communications Biology
  97. Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer
    Hong Zhang, Tao Zhu, Ruoqiu Fu, Peng Yang, Jing Peng, Wenchun Xu, Hong Wang, Sijie Li, Zhaoche Shu, Yibing Yin et al. · 2020 · Molecular Therapy — Oncolytics
  98. Recurring Gastrointestinal Infections Increase the Risk of Dementia
    Anne Fink, Gabriele Doblhammer, Gültekin Tamgüney · 2021 · Journal of Alzheimer s Disease
  99. Vitamin K2 Enhances Fat Degradation to Improve the Survival of C. elegans
    Zhi Qu, Lu Zhang, Wei Min Huang, Shanqing Zheng · 2022 · Frontiers in Nutrition
  100. SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis
    Shahrooz Amin Mozaffari, A. Salehi, Elnaz Mousavi, B. Zaman, A. Nassaj, F. Ebrahimzadeh, Hadi Nasiri, Zahra Valedkarimi, A. Adili, Ghazaleh Asemani et al. · 2022 · Pathology, Research and Practice